COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID among patients with autoimmune diseases, a US real-world study shows.

LOS ANGELES -- U.S. regulators issued new guidance this week shortening the time that people who received Moderna or Pfizer's COVID-19 vaccine have to wait for a booster, and it's different than the ...

The US Centers for Disease Control and Prevention strengthened recommendations for booster doses of coronavirus vaccine Monday, saying all adults should get boosted six months after the second dose of ...

Now in 2025, the TGA has registered Pfizer's LP.8.1 vaccine, designed specifically to target the spike protein of LP.8.1.

COVID-19 boosters significantly reduce hospitalization and ICU admissions in patients with cancer, but uptake remains low, necessitating targeted interventions to improve vaccination rates. Monovalent ...

NEW YORK (WABC) -- Pfizer is asking the FDA to amend its COVID-19 vaccine booster authorization to include all adults 18 and older. In September, the FDA and CDC authorized Pfizer booster shots after ...

Experts are concerned about a potential viral resurgence this fall, winter. With the end of summer nearing, and Labor Day around the corner, U.S. health officials are preparing to roll out millions of ...